Jaguar Health, Inc. (JAGX)
NASDAQ: JAGX · IEX Real-Time Price · USD
0.320
+0.017 (5.72%)
At close: Jun 24, 2022 4:00 PM
0.313
-0.007 (-2.188%)
Pre-market:
Jun 27, 2022 8:01 AM EDT
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|
|
Revenue
|
4.34 | 9.39 | 5.78 | 4.42 | 4.36 | 0.14 | 0.26 | 0 |
|
Revenue Growth (YoY)
|
-53.81% | 62.51% | 30.77% | 1.26% | 2981.61% | -45.23% | - | - |
|
Cost of Revenue
|
2.33 | 3.28 | 3.82 | 2.77 | 0.88 | 0.05 | 0.12 | 0 |
|
Gross Profit
|
2 | 6.11 | 1.96 | 1.65 | 3.48 | 0.09 | 0.13 | 0 |
|
Selling, General & Admin
|
26 | 21 | 20.44 | 22.11 | 14.33 | 6.47 | 6.1 | 4.1 |
|
Research & Development
|
15.08 | 6.41 | 5.82 | 5.15 | 4.27 | 7.21 | 6.48 | 4.22 |
|
Other Operating Expenses
|
1.63 | 5.34 | 4.65 | 5.21 | 19.13 | 0 | 0 | 0 |
|
Operating Expenses
|
42.71 | 32.75 | 30.91 | 32.47 | 37.73 | 13.68 | 12.58 | 8.32 |
|
Operating Income
|
-40.71 | -26.65 | -28.95 | -30.82 | -34.25 | -13.59 | -12.45 | -8.32 |
|
Interest Expense / Income
|
8.42 | 2.79 | 5.73 | 2.63 | 1.21 | 0.99 | 3.32 | 0.35 |
|
Other Expense / Income
|
3.47 | 4.37 | 3.85 | -1.31 | -0.31 | 0.16 | 0.53 | -0.05 |
|
Pretax Income
|
-52.6 | -33.81 | -38.53 | -32.15 | -35.15 | -14.73 | -16.29 | -8.61 |
|
Income Tax
|
0 | 0 | 0.01 | 0 | -13.18 | 0 | 0 | 0 |
|
Net Income
|
-52.6 | -33.81 | -38.54 | -32.15 | -21.97 | -14.73 | -16.29 | -8.61 |
|
Preferred Dividends
|
0 | 4.84 | 6.19 | 0 | 0 | 0 | 0.35 | 0.65 |
|
Net Income Common
|
-52.6 | -38.65 | -44.73 | -32.15 | -21.97 | -14.73 | -16.64 | -9.26 |
|
Shares Outstanding (Basic)
|
45 | 13 | 2 | 0 | 0 | 0 | 0 | 0 |
|
Shares Outstanding (Diluted)
|
45 | 13 | 2 | 0 | 0 | 0 | 0 | 0 |
|
Shares Change
|
247.12% | 678.25% | 2267.50% | 406.99% | 296.58% | 78.03% | 115.56% | - |
|
EPS (Basic)
|
-1.18 | -3.00 | -27.03 | -459.81 | -1.00 | -4.00 | -8.00 | -10.00 |
|
EPS (Diluted)
|
-1.18 | -3.00 | -27.03 | -459.81 | -1.00 | -4.00 | -8.00 | -10.00 |
|
Free Cash Flow Per Share
|
-0.78 | -1.19 | -12.36 | -325.24 | -712.52 | -4.00 | -7.00 | -5.00 |
|
Gross Margin
|
46.18% | 65.05% | 33.92% | 37.37% | 79.81% | 63.28% | 52.22% | - |
|
Operating Margin
|
-939.05% | -283.93% | -501.26% | -697.98% | -785.27% | -9599.84% | -4816.67% | - |
|
Profit Margin
|
-1213.26% | -411.81% | -774.48% | -727.92% | -503.73% | -10410.87% | -6439.30% | - |
|
Free Cash Flow Margin
|
-806.83% | -162.87% | -354.23% | -514.87% | -225.28% | -10258.35% | -5541.65% | - |
|
Effective Tax Rate
|
0.00% | 0.00% | -0.03% | 0.00% | 37.50% | 0.00% | 0.00% | 0.00% |
|
EBITDA
|
-42.37 | -28.74 | -30.87 | -28.2 | -33.36 | -13.7 | -12.97 | -8.26 |
|
EBITDA Margin
|
-977.30% | -306.20% | -534.54% | -638.53% | -764.83% | -9680.93% | -5019.37% | - |
|
Depreciation & Amortization
|
1.81 | 2.28 | 1.93 | 1.32 | 0.58 | 0.05 | 0.01 | 0 |
|
EBIT
|
-44.18 | -31.02 | -32.8 | -29.52 | -33.94 | -13.75 | -12.97 | -8.26 |
|
EBIT Margin
|
-1019.12% | -330.50% | -567.93% | -668.40% | -778.23% | -9714.49% | -5021.37% | - |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).